AAAAAA

   
Results: 1-15 |
Results: 15

Authors: MAHLER V ANTONI C ANHALT GJ KOCH HJ PETERS KP MANGER B KALDEN JR HORNSTEIN OP
Citation: V. Mahler et al., GRAFT-VERSUS-HOST-LIKE MUCOCUTANEOUS ERUPTIONS WITH SEROLOGICAL FEATURES OF PARANEOPLASTIC PEMPHIGUS AND SYSTEMIC LUPUS-ERYTHEMATOSUS IN A PATIENT WITH NON-HODGKINS-LYMPHOMA, Dermatology, 197(1), 1998, pp. 78-83

Authors: MAINI RN BREEDVELD FC KALDEN JR SMOLEN JS DAVIS D MACFARLANE JD ANTONI C LEEB B ELLIOTT MJ WOODY JN SCHAIBLE TF FELDMANN M
Citation: Rn. Maini et al., THERAPEUTIC EFFICACY OF MULTIPLE INTRAVENOUS INFUSIONS OF ANTITUMOR NECROSIS FACTOR-ALPHA MONOCLONAL-ANTIBODY COMBINED WITH LOW-DOSE WEEKLYMETHOTREXATE IN RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 41(9), 1998, pp. 1552-1563

Authors: KALDENNEMETH D GREBMEIER J ANTONI C MANGER B WOLF F KALDEN JR
Citation: D. Kaldennemeth et al., NMR MONITORING OF RHEUMATOID-ARTHRITIS PATIENTS RECEIVING ANTI-TNF-ALPHA MONOCLONAL-ANTIBODY THERAPY, Rheumatology international, 16(6), 1997, pp. 249-255

Authors: ANTONI C
Citation: C. Antoni, DUAL PROBLEMS AND SEPARATION OF SETS - LAGRANGE AND FENCHEL DUALITY, Journal of optimization theory and applications, 93(1), 1997, pp. 227-231

Authors: ANTONI C KAVANAUGH A RASCU A BRAAKMAN T MANGER B KALDEN J
Citation: C. Antoni et al., STANDARDIZATION OF JOINT EVALUATION PRIOR TO A MULTICENTER RHEUMATOID-ARTHRITIS (RA) TRIAL REDUCES VARIABILITY AMONG EXAMINERS, Arthritis and rheumatism, 40(9), 1997, pp. 386-386

Authors: MAINI RN BREEDVELD FC KALDEN JR SMOLEN JS DAVIS D MACFARLANE JD ANTONI C LEEB B ELLIOTT MJ WOODY JN SCHAIBLE TF FELDMANN M
Citation: Rn. Maini et al., LOW-DOSE METHOTREXATE (MTX) SUPPRESSES ANTI-GLOBULIN RESPONSES AND POTENTIATES EFFICACY OF A CHIMERIC MONOCLONAL ANTI-TNF-ALPHA ANTIBODY (CA2) GIVEN REPEATEDLY IN RHEUMATOID-ARTHRITIS (RA), Arthritis and rheumatism, 40(9), 1997, pp. 571-571

Authors: ANTONI C DALENA A
Citation: C. Antoni et A. Dalena, ON A PROBLEM OF ERDOS,P, Discrete applied mathematics, 66(1), 1996, pp. 75-79

Authors: ANTONI C
Citation: C. Antoni, LEAN PRODUCTION IN EUROPE - A MATTER OF TECHNICAL ADJUSTMENT OR CULTURAL-CHANGE, Applied psychology, 45(2), 1996, pp. 139-142

Authors: LORENZ HM ANTONI C VALERIUS T REPP R GRUNKE M SCHWERDTNER N NUSSLEIN H WOODY J KALDEN JR MANGER B
Citation: Hm. Lorenz et al., IN-VIVO BLOCKADE OF TNF-ALPHA BY INTRAVENOUS-INFUSION OF A CHIMERIC MONOCLONAL TNF-ALPHA ANTIBODY IN PATIENTS WITH RHEUMATOID-ARTHRITIS - SHORT-TERM CELLULAR AND MOLECULAR EFFECTS, The Journal of immunology, 156(4), 1996, pp. 1646-1653

Authors: KALDENNEMETH D GREBMEIER J ANTONI C MANGER B KALDEN JR
Citation: D. Kaldennemeth et al., A COMPUTERIZED AUTOMATED POST-PROCESSING MRI METHOD TO CONTROL SYNOVITIS IN PATIENTS WITH RHEUMATOID-ARTHRITIS UNDERGOING TREATMENT WITH BIOLOGICAL RESPONSE MODIFIERS, Arthritis and rheumatism, 39(9), 1996, pp. 446-446

Authors: LORENZ HM HIERONYMUS T GRUNKE M GEILER T ANTONI C WINKLER S NUSSLEIN H WOODY J KALDEN JR MANGER B
Citation: Hm. Lorenz et al., IN-VIVO BLOCKADE OF TNF-ALPHA IN PATIENTS WITH RHEUMATOID-ARTHRITIS -INDICATION FOR TACHYPHYLAXIS IN LONG-TERM EX-VIVO AND IN-VITRO EFFECTS AFTER REPEATED INFUSION OF CHIMERIC MONOCLONAL-ANTIBODY CA2, Arthritis and rheumatism, 39(9), 1996, pp. 1297-1297

Authors: ANTONI C MANGER B REICHSTETTER S SMOLEN J BREEDVELD F MAINI R BIJL H DEWOODY K KALDEN J WASSMUTH R
Citation: C. Antoni et al., THE HLA DR LOW AND DR4 HIGH-RESOLUTION BACKGROUND OF 55 PATIENTS WITHRHEUMATOID-ARTHRITIS TREATED WITH CA2 ANTIBODY AGAINST TUMOR-NECROSIS-FACTOR IN A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, Arthritis and rheumatism, 39(9), 1996, pp. 1298-1298

Authors: SIMMONSOBRIEN E CHEN S WATSON R ANTONI C PETRI M HOCHBERG M STEVENS MB PROVOST TT
Citation: E. Simmonsobrien et al., 100 ANTI-RO (SS-A) ANTIBODY-POSITIVE PATIENTS - A 10-YEAR FOLLOW-UP, Medicine, 74(3), 1995, pp. 109-130

Authors: ELLIOTT MJ MAINI RN FELDMANN M KALDEN JR ANTONI C SMOLEN JS LEEB B BREEDVELD FC MACFARLANE JD BIJL H WOODY JN
Citation: Mj. Elliott et al., RANDOMIZED DOUBLE-BLIND COMPARISON OF CHIMERIC MONOCLONAL-ANTIBODY TOTUMOR-NECROSIS-FACTOR-ALPHA (CA2) VERSUS PLACEBO IN RHEUMATOID-ARTHRITIS, Lancet, 344(8930), 1994, pp. 1105-1110

Authors: WOITH W NUSSLEIN I ANTONI C DEJICA DI WINKLER TH HERRMANN M PIRNER K KALDEN JR MANGER B
Citation: W. Woith et al., A SOLUBLE FORM OF THE HUMAN TRANSFERRIN RECEPTOR IS RELEASED BY ACTIVATED LYMPHOCYTES INVITRO, Clinical and experimental immunology, 92(3), 1993, pp. 537-542
Risultati: 1-15 |